Abstract
Peri-intraventricular hemorrhage (PIVH) is a serious condition for preterm infants, caused by traumatic or spontaneous rupture of the germinal matrix (GM) capillary network in the cerebral ventricles. It is a common source of morbidity and mortality in neonates, and risk correlates with earlier delivery, low birth weight, maternal–fetal infection, and vital sign derangements, among others. PIVH typically occurs in the first 72 h of life, and symptoms, when present, manifest most commonly within the first week of life. Prevention remains the primary goal in management, predominantly via prolonging of gestation. Current therapy protocols are center-dependent without consistent consensus guidelines, but infant positioning, homeostatic stabilization, and neuroprotection offer potential options. In this update of pharmacologic neuroprotective therapies for PIVH, we highlight commonly utilized therapies and review the investigative literature. Further multi-institutional clinical trials and basic research studies are required.
Similar content being viewed by others
Availability of data and materials
Not applicable for this study design.
References
Adams-Chapman I, Hansen NI, Stoll BJ, Higgins R, NICHD Research Network (2008) Neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion. Pediatrics 121:1167–1177. https://doi.org/10.1542/peds.2007-0423
Ahn SY, Chang YS, Sung SI, Park WS (2018) Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose-escalation clinical trial. Stem Cells Transl Med 7(12):847–856. https://doi.org/10.1002/sctm.17-0219 (Epub 2018 Aug 21. PMID: 30133179; PMCID: PMC6265626)
Ahn SY, Chang YS, Sung DK, Sung SI, Yoo HS, Im GH, Choi SJ, Park WS (2015) Optimal Route for Mesenchymal Stem Cells Transplantation after Severe Intraventricular Hemorrhage in Newborn Rats. PLoS ONE 10(7):e0132919. https://doi.org/10.1371/journal.pone.0132919 (PMID:26208299;PMCID:PMC4514759)
Al-Nuaimi SK, Mackenzie EM, Baker GB (2012) Monoamine oxidase inhibitors and neuroprotection: a review. Am J Ther 19(6):436–448. https://doi.org/10.1097/MJT.0b013e31825b9eb5 (PMID: 22960850)
Aly H, Elmahdy H, El-Dib M et al (2014) Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J Perinatol 35(3):186–191. https://doi.org/10.1038/jp.2014.186
Bada HS, Korones SB, Perry EH, Arheart KL, Ray JD, Pourcyrous M, Magill HL, Runyan W III, Somes GW, Clark FC, Tullis KV (1990) Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage. J Pediatr 117:607–614 (Childs Nerv Syst (2019) 35:917–927 92524)
Baker G, Matveychuk D, MacKenzie EM, Holt A, Wang Y, Kar S (2019) Attenuation of the effects of oxidative stress by the MAO-inhibiting antidepressant and carbonyl scavenger phenelzine. Chem Biol Interact 1(304):139–147. https://doi.org/10.1016/j.cbi.2019.03.003 (Epub 2019 Mar 8 PMID: 30857888)
Ballabh P (2010) Intraventricular hemorrhage in premature infants: mechanism of disease. Pediatr Res 67(1):1–8. https://doi.org/10.1203/PDR.0b013e3181c1b176
Ballabh P, Xu H, Hu F, Braun A, Smith K, Rivera A, Lou N, Ungvari Z, Goldman SA, Csiszar A, Nedergaard M (2007) Angiogenic inhibition reduces germinal matrix hemorrhage. Nat Med 13:477–485. https://doi.org/10.1038/nm1558
Ballard O, Morrow AL (2013) Human milk composition: nutrients and bioactive factors. Pediatr Clin N Am 60(1):49–74. https://doi.org/10.1016/j.pcl.2012.10.002
Bandstra ES, Montalvo BM, Goldberg RN, et al (2021) Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics. 1988;82(4):533–542. https://pubmed.ncbi.nlm.nih.gov/3174314/. Accessed 18 May 2021
Bayley N (2006) Bayley’s scales of infant and toddler development, 3rd edn. The Psychological Corporation, San Antonio
Braun A, Xu H, Hu F, Kocherlakota P, Siegel D, Chander P, Ungvari Z, Csiszar A, Nedergaard M, Ballabh P (2007) Paucity of pericytes in germinal matrix vasculature of premature infants. J Neurosci 27:12012–12024. https://doi.org/10.1523/JNEUROSCI.3281-07,2007
Brouwer A, Groenendaal F, van Haastert I-L, Rademaker K, Hanlo P, de Vries L (2008) Neurodevelopmental outcome of preterm infants with severe intraventricular hemorrhage and therapy for posthemorrhagic ventricular dilatation. J Pediatr 152:648–654. https://doi.org/10.1016/j.jpeds.2007.10.005
Canterino JC, Verma UL, Visintainer PF et al (1999) Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage. Obstet Gynecol 93:396–402
Carloni S, Perrone S, Buonocore G, Longini M, Proietti F, Balduini W (2008) Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 44(2):157–164. https://doi.org/10.1111/j.1600-079x.2007.00503.x
Chen Z, Zhang J, Chen Q, Guo J, Zhu G, Feng H (2014) Neuroprotective effects of edaravone after intraventricular hemorrhage in rats. NeuroReport 25(9):635–640. https://doi.org/10.1097/wnr.0000000000000050
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT04225286. Intranasal Human Milk for Intraventricular Hemorrhage; 2020 Jan 13 [cited 2021 May 15]. https://www.clinicaltrials.gov/ct2/show/NCT04225286?recrs=ad&cond=intraventricular+hemorrhage&draw=2&rank=1.
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT 02076373. Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair). 2014 March 3 [cited 2021 May 15]. https://www.clinicaltrials.gov/ct2/show/NCT02076373?recrs=ad&cond=intraventricular+hemorrhage&draw=2&rank=4.
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT02673788. Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage. 2016 Feb 4 [cited 2021 May 15]. https://www.clinicaltrials.gov/ct2/show/NCT02673788?recrs=ad&cond=intraventricular+hemorrhage&draw=2&rank=5.
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT00515281. Inhaled Nitric Oxide and Neuroprotection in Premature Infants (NOVA2). 2007 Aug 13 [cited 2021 May 15]. https://www.clinicaltrials.gov/ct2/show/NCT00515281?recrs=ad&cond=intraventricular+hemorrhage&draw=2&rank=11.
ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29. Identifier NCT02221219. Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury. 2014 Aug 20 [cited 2021 15 May]. https://www.clinicaltrials.gov/ct2/show/NCT02221219?recrs=ad&cond=intraventricular+hemorrhage&draw=2&rank=15.
DailyMed - RADICAVA- edaravone injection. dailymed.nlm.nih.gov. Published March 22, 2021. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ce2c1c4-2a40-485c-b7cb-96a9b85d9d11. Accessed 18 May 2021.
du Plessis AJ (2009) The role of systemic hemodynamic disturbances in prematurity-related brain injury. J Child Neurol 24:1127–1140
du Plessis AJ (2008) Cerebrovascular injury in premature infants: current understanding and challenges for future prevention. Clin Perinatol 35:609–641. https://doi.org/10.1016/j.clp.2008.07.010
El-Khoury N, Braun A, Hu F et al (2006) Astrocyte end-feet in germinal matrix, cerebral cortex, and white matter in developing infants. Pediatr Res 59:673–679. https://doi.org/10.1203/01.pdr.0000214975.85311.9c
Fanaroff JM, Fanaroff AA (2012) Blood pressure disorders in the neonate: hypotension and hypertension. Neonatol A Pract Approach to Neonatal Dis. https://doi.org/10.1007/978-88-470-1405-3_78
Fauchère JC, Koller BM, Tschopp A et al (2015) Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants. J Pediatr 167(1):52-7.e1–3. https://doi.org/10.1016/j.jpeds.2015.02.052
Ferreira DM, Girão ALA, E Silva AVS et al (2020) Application of a bundle in the prevention of peri-intraventricular hemorrhage in preterm newborns. J Perinat Neonatal Nurs 34(2):E5–E11. https://doi.org/10.1097/JPN.0000000000000482
Goddard-Finegold J, Armstrong DL (1987) Reduction in incidence of periventricular, intraventricular hemorrhages in hypertensive newborn beagles pretreated with phenobarbital. Pediatrics 79(6):901–906
Griffiths R (1984) The abilities of young children: a comprehensive system of mental measurement for the first eight years of life. Test Agency Ltd, London
Han RH, McKinnon A, CreveCoeur TS et al (2018) Predictors of mortality for preterm infants with intraventricular hemorrhage: a population-based study. Childs Nerv Syst 34(11):2203–2213. https://doi.org/10.1007/s00381-018-3897-4
Hierro-Bujalance C, Infante-Garcia C, Sanchez-Sotano D et al (2020) Erythropoietin improves atrophy, bleeding and cognition in the newborn intraventricular hemorrhage. Front Cell Dev Biol 8:571258. https://doi.org/10.3389/fcell.2020.571258
Hoekstra RE, Ferrara TB, Couser RJ, Payne NR, Connett JE (2004) Survival and longterm neurodevelopmental outcome of extremely premature infants born at 23–26 weeks’ gestational age at a tertiary center. Pediatrics 113(1 pt 1). www.pediatrics.org/cgi/content/full/113/1/e1
Hutchison AA, Ogletree ML, Palmo CJH (1985) et a Plasma 6- keto prostaglandin Fla and thromboxane B2 concentrations in preterm neonates during the first three postnatal days: Association with intracranial hemorrhage, the idiopathic respiratory distress syndrome and patent ductus arteriosus. Prostaglandins Leukotrienes Med 18:163–181
Jaleel MA, Rosenfeld CR (2013) Patent ductus arteriosus and intraventricular hemorrhage: a complex association. J Pediatr 163(1):8–10. https://doi.org/10.1016/j.jpeds.2013.01.043
Kaiser JR, Gauss CH, Williams DK (2005) The effects of hypercapnia on cerebral autoregulation in ventilated very low birth weight infants. Pediatr Res 58:931–935. https://doi.org/10.1203/01.pdr.0000182180.80645.0c
Keller T, Körber F, Oberthuer A, Schafmeyer L, Mehler K, Kuhr K, Kribs A (2019) Intranasal breast milk for premature infants with severe intraventricular hemorrhage-an observation. Eur J Pediatr 178(2):199–206. https://doi.org/10.1007/s00431-018-3279-7
Khanafer-Larocque I, Soraisham A, Stritzke A et al (2019) Intraventricular hemorrhage: risk factors and association with patent ductus arteriosus treatment in extremely preterm neonates. Front Pediatr 7:10. https://doi.org/10.3389/fped.2019.00408
Kiechl-Kohlendorfer U, Ralser E, Pupp Peglow U, Pehboeck-Walser N, Fussenegger B (2013) Early risk predictors for impaired numerical skills in 5-year-old children born before 32 weeks of gestation. Acta Paediatr 102(1):66–71
Klebermass-Schrehof K, Czaba C, Olischar M et al (2012) Impact of low-grade intraventricular hemorrhage on longterm neurodevelopmental outcome in preterm infants. Childs Nerv Syst 28(12):2085–2092
Leijser LM, Miller SP, van Wezel-Meijler G, Brouwer AJ, Traubici J, van Haastert IC, Whyte HE, Groenendaal F, Kulkarni AV, Han KS, Woerdeman PA, Church PT, Kelly EN, van Straaten HLM, Ly LG, de Vries LS (2018) Posthemorrhagic ventricular dilatation in preterm infants: when best to intervene? Neurology 90(8):e698–e706. https://doi.org/10.1212/WNL.0000000000004984 (Epub 2018 Jan 24. PMID: 29367448; PMCID: PMC5818161)
McNally MA, Soul JS (2019) Pharmacologic prevention and treatment of neonatal brain injury. Clin Perinatol 46(2):311–325. https://doi.org/10.1016/j.clp.2019.02.006
Ment LR, Oh W, Philip AGS, Ehrenkranz RA, Duncan CC, Allan W, Taylor KJW, Schneider K, Katz KH, Makuch RW (1992) Risk factors for early intraventricular hemorrhage in low birth weight infants. J Pediatr 121:776–783. https://doi.org/10.1016/S0022-3476(05)81915-8
Miall-Allen VM, de Vries LS, Whitelaw AG (1987) Mean arterial blood pressure and neonatal cerebral lesions. Arch Dis Child 62:1068–1069. https://doi.org/10.1542/neo.8-1-e32
Mitra S, Florez ID, Tamayo ME et al (2018) Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants. JAMA 319(12):1221. https://doi.org/10.1001/jama.2018.1896
Miyaji Y, Yoshimura S, Sakai N et al (2015) Effect of edaravone on favorable outcome in patients with acute cerebral large vessel occlusion: subanalysis of RESCUE-Japan Registry. Neurol Med Chir 55(3):241–247. https://doi.org/10.2176/nmc.ra.2014-0219
Mukerji A, Shah V, Shah PS (2015) Periventricular/intraventricular hemorrhage and neurodevelopmental outcomes: a meta-analysis. Pediatrics 136:1132–1143. https://doi.org/10.1542/peds.2015-0944
Nelson KB, Grether JK (1995) Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95:263–269
Pandya CD, Vekaria H, Joseph B, Slone SA, Gensel JC, Sullivan PG, Miller BA (2021) Hemoglobin induces oxidative stress and mitochondrial dysfunction in oligodendrocyte progenitor cells. Transl Res 231:13–23. https://doi.org/10.1016/j.trsl.2021.01.005 (Epub 2021 Jan 15. PMID: 33460824; PMCID: PMC8016702)
Papile LA, Burstein J, Burstein R, Koffler H (1978) Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92(4):529–534
Park WS, Ahn SY, Sung SI, Ahn JY, Chang YS (2017) Mesenchymal stem cells: the magic cure for intraventricular hemorrhage? Cell Transplant 26(3):439–448. https://doi.org/10.3727/096368916X694193 (Epub 2016 Nov 30. PMID: 27938484; PMCID: PMC5657702)
Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment? Front Aging Neurosci. https://doi.org/10.3389/fnagi.2017.00068
Radic JAE, Vincer M, McNeely PD (2015) Outcomes of intraventricular hemorrhage and posthemorrhagic hydrocephalus in a population-based cohort of very preterm infants born to residents of Nova Scotia from 1993 to 2010. J Neurosurg Pediatr 15:580–588. https://doi.org/10.3171/2014.11.PEDS14364
Robertson NJ, Faulkner S, Fleiss B et al (2012) Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain 136(1):90–105. https://doi.org/10.1093/brain/aws285
Robinson S (2012) Neonatal posthemorrhagic hydrocephalus from prematurity: pathophysiology and current treatment concepts. J Neurosurg Pediatr 9:1–23. https://doi.org/10.1088/1367-2630/15/1/015008
Robinson S, Conteh FS, Oppong AY, Yellowhair TR, Newville JC, Demerdash NE, Shrock CL, Maxwell JR, Jett S, Northington FJ, Jantzie LL (2018) Extended combined neonatal treatment with erythropoietin plus melatonin prevents posthemorrhagic hydrocephalus of prematurity in rats. Front Cell Neurosci 25(12):322. https://doi.org/10.3389/fncel.2018.00322
Sherlock RL, Anderson PJ, Doyle LW, Victorian Infant Collaborative Study Group (2005) Neurodevelopmental sequelae of intraventricular haemorrhage at 8 years of age in a regional cohort of ELBW/very preterm infants. Early Hum Dev 81(11):909–916
Song J, Wang Y, Xu F, Sun H, Zhang X, Xia L, Zhang S, Li K, Peng X, Li B, Zhang Y, Kang W, Wang X, Zhu C (2021) Erythropoietin improves poor outcomes in preterm infants with intraventricular hemorrhage. CNS Drugs 35(6):681–690. https://doi.org/10.1007/s40263-021-00817-w
Starr R, De Jesus O, Borger J (2021) Periventricular Hemorrhage-Intraventricular Hemorrhage. In: StatPearls. StatPearls Publishing; 2021. http://www.ncbi.nlm.nih.gov/books/NBK538310/. Accessed 18 May 2021
Steen PA, Mitchelfelder JD (1979) Barbiturate protection in tolerant and nontolerant hypoxic mice: comparison with hypothermic protection. Anesthesiology 50:404–408 (MEDLINE: 1979207371)
Strunk T (2004) Does erythropoietin protect the preterm brain? Arch Dis Childh Fetal and Neonatal Ed 89(4):F364–F366. https://doi.org/10.1136/adc.2003.041533
Szpecht D, Szymankiewicz M, Nowak I, Gadzinowski J (2016) Intraventricular hemorrhage in neonates born before 32 weeks of gestation—retrospective analysis of risk factors. Childs Nerv Syst 32:1399–1404. https://doi.org/10.1007/s00381-016-3127-x
Titomanlio L, Kavelaars A, Dalous J, Mani S, El Ghouzzi V, Heijnen C, Baud O, Gressens P (2011) Stem cell therapy for neonatal brain injury: perspectives and challenges. Ann Neurol 70(5):698–712. https://doi.org/10.1002/ana.22518 (PMID: 22162055)
Valdez Sandoval P, Hernández Rosales P, Quiñones Hernández DG, Chavana Naranjo EA, García NV (2019) Intraventricular hemorrhage and posthemorrhagic hydrocephalus in preterm infants: diagnosis, classification, and treatment options. Child’s Nervous Syst 35(6):917–927. https://doi.org/10.1007/s00381-019-04127-x
Weintraub Z, Solovechick M, Reichman B et al (2001) Effect of maternal tocolysis on the incidence of severe periventricular/intraventricular haemorrhage in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 85:F13–F17
Whitelaw A, Odd D (2007) Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants. In: Whitelaw A (ed) Cochrane Database of Systematic Reviews. Published online October 17, 2007. https://doi.org/10.1002/14651858.cd001691.pub2.
Wimberley PD, Lou HC, Pedersen H, Hejl M, Lassen NA, Friis-Hansen B (1982) Hypertensive peaks in the pathogenesis of intraventricular hemorrhage in the newborn. Abolition by phenobarbitone sedation. Acta Paediatr Scand 71:537–542
Xu H, Hu F, Sado Y, Ninomiya Y, Borza DB, Ungvari Z, LaGamma EF, Csiszar A, Nedergaard M, Ballabh P (2008) Maturational changes in laminin, fibronectin, collagen IV, and perlecan in germinal matrix, cortex, and white matter and effect of betamethasone. J Neurosci Res 86:1482–1500. https://doi.org/10.1002/jnr.21618
Zeng X, Xue Y, Tian Q, Sun R, An R (2016) Effects and safety of magnesium sulfate on neuroprotection. Medicine 95(1):e2451. https://doi.org/10.1097/md.0000000000002451
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Contributions
Conception and design of study: TR; acquisition of data: MK and TR; analysis and/or interpretation of data: MK, TR, and EM; drafting the manuscript: MK, TR, EM, and GK; revising the manuscript critically for important intellectual content: MK, BW, and TH; approval of the version of the manuscript to be published: all authors.
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethics approval
Not applicable for this study design.
Consent to participate
Not applicable for this study design.
Consent to publish
Not applicable for this study design.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Reardon, T., Koller, G., Kortz, M.W. et al. Pharmacological neuroprotection and clinical trials of novel therapies for neonatal peri-intraventricular hemorrhage: a comprehensive review. Acta Neurol Belg 122, 305–314 (2022). https://doi.org/10.1007/s13760-022-01889-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-022-01889-1